Skip to main content
Erschienen in: Journal of Anesthesia 3/2014

01.06.2014 | Original Article

The impact of pretreatment with bolus dose of enteral glutamine on acute lung injury induced by oleic acid in rats

verfasst von: A. Ebru Salman, Fahri Yetişir, Mehmet Kılıç, Özkan Önal, Ahmet Dostbil, Dilara Zeybek, Mustafa Aksoy, Figen Kaymak, Tuğrul Çelik, Süheyla Ünver

Erschienen in: Journal of Anesthesia | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Both parenteral and enteral glutamine have shown beneficial effects in sepsis and ischemia/reperfusion-induced acute lung injury (ALI). Oleic acid (OA) has been used to induce ALI in experimental studies. In this study, we investigated the effects of pretreatment of a bolus dose of enteral glutamine on ALI induced by OA in rats.

Methods

Twenty-eight adult female Sprague–Dawley rats weighing 240–300 g were divided into four groups, 7 in each. Group I and group II received normal saline for 30 days, group III and group IV received glutamine at a dose of 1 g/kg for 10 days by gavage, and in group II and group IV 100 mg/kg OA was administered i.v. Histopathological examination of the lung was performed with light and electron microscopy. Levels of protein carbonyl, malondialdehyde, superoxide dismutase, catalase, and glutathione peroxidase levels were measured in tissue samples. Levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, and total tissue oxidant status and total tissue antioxidant status were measured in serum samples.

Results

Light microscopy showed that the total lung injury score of group IV was significantly lower than group II. Change in thickness of the fused basal lamina was not significantly different in groups II and IV under electron microscopy. TNF-α, IL-6, and IL-10 serum levels were higher in group II when compared to group I and significantly attenuated in group IV.

Conclusion

Pretreatment with a bolus dose of enteral glutamine minimized the extent of ALI induced by OA in rats.
Literatur
1.
Zurück zum Zitat Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc. 2006;81:205–12.PubMedCrossRef Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc. 2006;81:205–12.PubMedCrossRef
2.
Zurück zum Zitat Raghavendran K, Pryhuber GS, Chess PR, Davidson BA, Knight PR, Noter RH. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem. 2008;15:1911–24.PubMedCentralPubMedCrossRef Raghavendran K, Pryhuber GS, Chess PR, Davidson BA, Knight PR, Noter RH. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome. Curr Med Chem. 2008;15:1911–24.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat McGuigan RM, Mullenix P, Norlund LL, Ward D, Walts M, Azarow K. Acute lung injury using oleic acid in the laboratory rat: establishment of a working model and evidence against free radicals in the acute phase. Curr Surg. 2003;60:412–7.PubMedCrossRef McGuigan RM, Mullenix P, Norlund LL, Ward D, Walts M, Azarow K. Acute lung injury using oleic acid in the laboratory rat: establishment of a working model and evidence against free radicals in the acute phase. Curr Surg. 2003;60:412–7.PubMedCrossRef
5.
Zurück zum Zitat Rylander C, Hogman M, Perchiazzi G, Magnusson A, Hedestierna G. Oleic acid lung injury: a morphometric analysis using computed tomography. Acta Anaesthesiol Scand. 2004;48:1123–9.PubMedCrossRef Rylander C, Hogman M, Perchiazzi G, Magnusson A, Hedestierna G. Oleic acid lung injury: a morphometric analysis using computed tomography. Acta Anaesthesiol Scand. 2004;48:1123–9.PubMedCrossRef
6.
Zurück zum Zitat DiRocco JD, Pavone LA, Carney DE, Lutz CJ, Gatto LA, Landas SK, Nieman GF. Dynamic alveolar mechanics in four models of lung injury. Intensive Care Med. 2006;32:140–8.PubMedCrossRef DiRocco JD, Pavone LA, Carney DE, Lutz CJ, Gatto LA, Landas SK, Nieman GF. Dynamic alveolar mechanics in four models of lung injury. Intensive Care Med. 2006;32:140–8.PubMedCrossRef
7.
Zurück zum Zitat Hou YC, Pai MH, Hu YM, Yeh SL. Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. Am J Physiol Lung Cell Mol Physiol. 2009;3:288–95.CrossRef Hou YC, Pai MH, Hu YM, Yeh SL. Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. Am J Physiol Lung Cell Mol Physiol. 2009;3:288–95.CrossRef
8.
Zurück zum Zitat Singleton KD, Serkova N, Banerjee A, Meng X, Gamboni-Robertson F, Wischmeyer PE. Glutamine attenuates endotoxin induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition. 2005;21:214–23.PubMedCrossRef Singleton KD, Serkova N, Banerjee A, Meng X, Gamboni-Robertson F, Wischmeyer PE. Glutamine attenuates endotoxin induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition. 2005;21:214–23.PubMedCrossRef
9.
Zurück zum Zitat Wichmeyer PE. Glutamine: mode of action in critical illness. Crit Care Med. 2007;35:541–4.CrossRef Wichmeyer PE. Glutamine: mode of action in critical illness. Crit Care Med. 2007;35:541–4.CrossRef
10.
Zurück zum Zitat Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003;27:241–5.PubMedCrossRef Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003;27:241–5.PubMedCrossRef
11.
Zurück zum Zitat O’Dwyer ST, Smith RJ, Hwang TL, Wilmore DW. Maintenance of small bowel mucosa with glutamine enriched parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989;13:579–85.PubMedCrossRef O’Dwyer ST, Smith RJ, Hwang TL, Wilmore DW. Maintenance of small bowel mucosa with glutamine enriched parenteral nutrition. JPEN J Parenter Enteral Nutr. 1989;13:579–85.PubMedCrossRef
12.
Zurück zum Zitat Singleton KD, Wischmeyer PE. Glutamine’s protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Phsiol. 2007;292:R1839–45.CrossRef Singleton KD, Wischmeyer PE. Glutamine’s protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Phsiol. 2007;292:R1839–45.CrossRef
13.
Zurück zum Zitat He X, Han B, Mura M, Xia S, Wang S, Ma T, Liu M, Liu Z. Angiotensin converting enzyme inhibitor captopril prevents oleic acid induced severe acute lung injury in rats. Shock. 2007;28:106–11.PubMedCrossRef He X, Han B, Mura M, Xia S, Wang S, Ma T, Liu M, Liu Z. Angiotensin converting enzyme inhibitor captopril prevents oleic acid induced severe acute lung injury in rats. Shock. 2007;28:106–11.PubMedCrossRef
14.
Zurück zum Zitat Wang HM, Bodenstein M, Markstaller K. Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res. 2008;40:305–16.PubMedCrossRef Wang HM, Bodenstein M, Markstaller K. Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res. 2008;40:305–16.PubMedCrossRef
15.
Zurück zum Zitat Zhou Z, Kozlowski J, Schuster DP. Physiologic, biochemical, and imaging characterization of acute lung injury in mice. Am J Respir Crit Care Med. 2005;172:344–51.PubMedCentralPubMedCrossRef Zhou Z, Kozlowski J, Schuster DP. Physiologic, biochemical, and imaging characterization of acute lung injury in mice. Am J Respir Crit Care Med. 2005;172:344–51.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27:337–49.PubMedCrossRef Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27:337–49.PubMedCrossRef
17.
Zurück zum Zitat Liu H, Zhang D, Zhao B, Zhao J. Superoxide anion, the main species of ROS in the development of ARDS induced by oleic acid. Free Radical Res. 2004;38:1281–7.CrossRef Liu H, Zhang D, Zhao B, Zhao J. Superoxide anion, the main species of ROS in the development of ARDS induced by oleic acid. Free Radical Res. 2004;38:1281–7.CrossRef
18.
Zurück zum Zitat Larrick IW, Kunkell SL. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharm Res. 1988;5:129–39.PubMedCrossRef Larrick IW, Kunkell SL. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharm Res. 1988;5:129–39.PubMedCrossRef
20.
Zurück zum Zitat Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523–35.PubMedCrossRef Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14:523–35.PubMedCrossRef
21.
Zurück zum Zitat Ito K, Mizutani A, Kira S, Mori M, Iwasaka H, Noguchi T. Effect of ulinastatin, a human urinary trypsin inhibitor, on the oleic acid induced acute lung injury in rats via the inhibition of activated leucocytes. Injury. 2005;36:387–94.PubMedCrossRef Ito K, Mizutani A, Kira S, Mori M, Iwasaka H, Noguchi T. Effect of ulinastatin, a human urinary trypsin inhibitor, on the oleic acid induced acute lung injury in rats via the inhibition of activated leucocytes. Injury. 2005;36:387–94.PubMedCrossRef
22.
Zurück zum Zitat Chen HI, Hsieh NK, Kao SJ, Su CF. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med. 2008;36:1214–20.PubMedCrossRef Chen HI, Hsieh NK, Kao SJ, Su CF. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med. 2008;36:1214–20.PubMedCrossRef
23.
Zurück zum Zitat Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27:355–73.PubMedCrossRef Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27:355–73.PubMedCrossRef
24.
Zurück zum Zitat Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, Ebner C, Hartl W, Heymann C, Spies C. ESPEN guidelines on enteral nutrition: intensive care. Clin Nut. 2006;25:210–23. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, Ebner C, Hartl W, Heymann C, Spies C. ESPEN guidelines on enteral nutrition: intensive care. Clin Nut. 2006;25:210–23.
25.
Zurück zum Zitat Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DW. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg. 1992;215:114–9.PubMedCentralPubMedCrossRef Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DW. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg. 1992;215:114–9.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980–90.PubMedCrossRef Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980–90.PubMedCrossRef
27.
Zurück zum Zitat Singleton KD, Beckey VE, Wishmeyer PE. Glutamine prevents activation of NF-kappa B and stress kinase pathways attenuates inflammatory cytokine release and prevents acute respiratory distress (ARDS) syndrome following sepsis. Shock. 2005;24:583–9.PubMedCrossRef Singleton KD, Beckey VE, Wishmeyer PE. Glutamine prevents activation of NF-kappa B and stress kinase pathways attenuates inflammatory cytokine release and prevents acute respiratory distress (ARDS) syndrome following sepsis. Shock. 2005;24:583–9.PubMedCrossRef
28.
Zurück zum Zitat Oliviera GP, Oliviera MBG, Santos RS, Lima LD, Dias CM, Saber AMAB, et al. Intravenous glutamine decreases lung and distal organ injury in experimental model of abdominal sepsis. Crit Care. 2009;13:R74. doi:10.1186/cc7888.CrossRef Oliviera GP, Oliviera MBG, Santos RS, Lima LD, Dias CM, Saber AMAB, et al. Intravenous glutamine decreases lung and distal organ injury in experimental model of abdominal sepsis. Crit Care. 2009;13:R74. doi:10.​1186/​cc7888.CrossRef
Metadaten
Titel
The impact of pretreatment with bolus dose of enteral glutamine on acute lung injury induced by oleic acid in rats
verfasst von
A. Ebru Salman
Fahri Yetişir
Mehmet Kılıç
Özkan Önal
Ahmet Dostbil
Dilara Zeybek
Mustafa Aksoy
Figen Kaymak
Tuğrul Çelik
Süheyla Ünver
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 3/2014
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-013-1745-y

Weitere Artikel der Ausgabe 3/2014

Journal of Anesthesia 3/2014 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.